Other

Clinical Research: Phase 1 - Phase 4

Full Service or FSP? How to Choose the Right Model for Your Study

Typically, when people talk about a full-service contract research organization (CRO) they mean a group that handles every aspect of a clinical study, supplying the personnel, the systems, and the processes. The sponsor is spared all operational involvement with the full-service model, simply receiving key information at specified intervals. This model works very well for...

Functional Service Provider (FSP)

Staying Relevant: Forward Motion in Clinical Data Management

Industry wide, the past two years have seen rapid changes in the approach to clinical data management. To some extent, this is the natural result of working through a pandemic, where remote collaboration and efficiency are at a premium. Yet the seeds of change were planted far earlier, with artificial intelligence, data visualization, and other...

Functional Service Provider (FSP)

FSP: The Access Point to Better Clinical Data Management

At its core, the success of any clinical trial rests on clean, conclusive data. This creates challenges. Throughout a trial, the data must be properly aggregated, scrubbed, analyzed, acted on—and all those steps must be recorded, to assure regulatory authorities of their accuracy. As the industry continues to evolve, new solutions to these challenges have...

Clinical Research: Phase 1 - Phase 4

Pharmaceutical Outsourcing: Decentralized Clinical Trials

Patient centricity—also known as patient-centered care—has been a growing force across healthcare. Like the consumer-driven change in other industries, patient centricity upends established models. Whereas traditionally, healthcare professionals dictate care decisions with little consideration for the patient’s desires, patient-centric care puts the patient first. Its tenets include:  • Empowering patients through technology • Reducing inconvenience...

Clinical Research: Phase 1 - Phase 4

Clinical Researcher: Preparing for the Future

In July 2021, the Industry Standard Research (ISR) Report on Hybrid/Virtual/Decentralized Clinical Trials Market Outlook surveyed 109 industry leaders worldwide who had been involved in DCTs over the past year.{1} Respondents anticipated a 12% increase in hybrid trials over the next two years—and predicted that DCTs would outstrip traditional trial models within three years. They...

Clinical Research: Phase 1 - Phase 4

Study Start-Up: Why You Really Need to Get This Right

You get one chance to initiate a clinical trial. Botch the start-up and you’ll expend great effort correcting course and playing catch-up. The waste of money and time — commodities that are chronically scarce among the biotech and specialty pharma companies that comprise most of our customer base — can be devastating. That’s why we...

Clinical Research: Phase 1 - Phase 4

Pharmaceutical Outsourcing: Reimagining the Patient Experience in an Evolving Clinical Trial Regulatory Landscape

“Patient centricity” has long been a guiding principle of clinical trial design and conduct, and it has become even more critical in the COVID era as trial sponsors and regulatory authorities have had to adapt to a continually shifting landscape. Pandemic-related restrictions have prompted substantial changes in how clinical trials are developed and implemented, requiring...

Other

CNS Summit

Sponsorship

Functional Service Provider (FSP)

Outsourcing in Clinical Trials (OCT) UK & Ireland

December 8th – 9th , 2021 London, UK Booth 13 Visit Premier Research at Booth 13 at Outsourcing in Clinical Trials (OCT) UK & Ireland to discuss the common challenges and trends impacting the region such as COVID, steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs...

Functional Service Provider (FSP)

Outsourcing in Clinical Trials (OCT) Southern California

December 7th – 8th , 2021 La Jolla, CA Booth 36 Visit Premier Research at Booth 36 at Outsourcing in Clinical Trials (OCT) Southern California to discuss the common challenges and trends impacting the region such as COVID, steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs...